October 31, 2016
Sanofi submits corrective action plan to the FDA regarding the BLA for sarilumab
Sanofi and Regeneron Pharmaceuticals have announced the FDA issued a Complete Response Letter (CRL) regarding…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: BLA